Talaporfin-13C4,15N

Talaporfin-13C4,15N (ME2906 (free acid) -13C4,15N) is the 13C- and 15N-labeled Talaporfin (HY-16477A) . Talaporfin sodium, can be used in intraoperative photodynamic therapy (PDT) with a 664-nm semiconductor laser, was evaluated for efficacy and safety in treating primary malignant parenchymal brain tumors[1].

Product Specifications

Product Name Alternative

ME2906 (free acid) -13C4,15N; Mono-L-aspartyl chlorin e6 (free acid) -13C4,15N; NPe6 (free acid) -13C4,15N

UNSPSC

12352005

Target

Isotope-Labeled Compounds; Photosensitizer

Related Pathways

Apoptosis; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

CC1=C2/C=C(N=C3/C(CC([15N]([13C@@H]([13CH2][13C](O)=O)[13C](O)=O)[H])=O)=C(N/C4=C\C(C(CC)=C/5C)=NC5=C/C(N2)=C1C=C)/C(C(O)=O)=C4C)/[C@H]([C@@H]3CCC(O)=O)C

Molecular Formula

C34 13C4H41N4 15NO9

Molecular Weight

716.72

References & Citations

[1]Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors